Department of Pharmacology and Experimental Neuroscience and Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, NE, USA.
J Neuroimmune Pharmacol. 2012 Jun;7(2):352-62. doi: 10.1007/s11481-011-9335-y. Epub 2012 Jan 7.
There is a rebirth of humanized mouse models in reflecting human immunodeficiency virus (HIV) pathobiology. This has allowed new investigations of viral diversity, immunity and developmental therapeutics. In the past, HIV infection and disease were, in part, mirrored in immune deficient mice reconstituted with human hematopoietic stem cells. What remained from early studies reflected the ability to mirror central nervous system (CNS) disease. As the wide spread use of combination antiretroviral therapies has changed the severity, but not prevalence, of HIV-associated neurocognitive disorders (HAND), mimicking such virus-induced CNS morbidities in humanized animals is essential for HIV/AIDS research activities. To this end, we now review the evidence for how and under what circumstances humanized mice may be utilized for studies of HIV-1 neuropathogenesis.
在反映人类免疫缺陷病毒 (HIV) 发病机制方面,人性化小鼠模型正在复兴。这使得对病毒多样性、免疫和发展治疗学的新研究成为可能。过去,部分 HIV 感染和疾病在用人造血干细胞重建的免疫缺陷小鼠中得到了反映。早期研究反映了反映中枢神经系统 (CNS) 疾病的能力。随着联合抗逆转录病毒疗法的广泛应用改变了与 HIV 相关的认知障碍 (HAND) 的严重程度,但并未改变其流行程度,因此在人类化动物中模拟此类病毒诱导的 CNS 疾病对于 HIV/AIDS 研究活动至关重要。为此,我们现在回顾了有关在何种情况下以及在何种情况下可以使用人类化小鼠来研究 HIV-1 神经发病机制的证据。